BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 35040104)

  • 1. Novel benzimidazole derivatives; synthesis, bioactivity and molecular docking study as potent urease inhibitors.
    Saeedian Moghadam E; Al-Sadi AM; Talebi M; Amanlou M; Amini M; Abdel-Jalil R
    Daru; 2022 Jun; 30(1):29-37. PubMed ID: 35040104
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design, molecular docking and synthesis of novel 5,6-dichloro-2-methyl-1H-benzimidazole derivatives as potential urease enzyme inhibitors.
    Menteşe E; Emirik M; Sökmen BB
    Bioorg Chem; 2019 May; 86():151-158. PubMed ID: 30710848
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis, in vitro urease inhibitory potential and molecular docking study of Benzimidazole analogues.
    Zaman K; Rahim F; Taha M; Ullah H; Wadood A; Nawaz M; Khan F; Wahab Z; Shah SAA; Rehman AU; Kawde AN; Gollapalli M
    Bioorg Chem; 2019 Aug; 89():103024. PubMed ID: 31176853
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and molecular docking study of some 5,6-dichloro-2-cyclopropyl-1H-benzimidazole derivatives bearing triazole, oxadiazole, and imine functionalities as potent inhibitors of urease.
    Menteşe E; Bektaş H; Sokmen BB; Emirik M; Çakır D; Kahveci B
    Bioorg Med Chem Lett; 2017 Jul; 27(13):3014-3018. PubMed ID: 28526368
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 5-Bromo-2-aryl benzimidazole derivatives as non-cytotoxic potential dual inhibitors of α-glucosidase and urease enzymes.
    Arshad T; Khan KM; Rasool N; Salar U; Hussain S; Asghar H; Ashraf M; Wadood A; Riaz M; Perveen S; Taha M; Ismail NH
    Bioorg Chem; 2017 Jun; 72():21-31. PubMed ID: 28346872
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New Triazinoindole Bearing Benzimidazole/Benzoxazole Hybrids Analogs as Potent Inhibitors of Urease: Synthesis, In Vitro Analysis and Molecular Docking Studies.
    Mumtaz S; Iqbal S; Shah M; Hussain R; Rahim F; Rehman W; Khan S; Abid OU; Rasheed L; Dera AA; Al-Ghulikah HA; Kehili S; Elkaeed EB; Alrbyawi H; Alahmdi MI
    Molecules; 2022 Oct; 27(19):. PubMed ID: 36235116
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New 1,2,3-triazole-(thio)barbituric acid hybrids as urease inhibitors: Design, synthesis, in vitro urease inhibition, docking study, and molecular dynamic simulation.
    Asgari MS; Azizian H; Nazari Montazer M; Mohammadi-Khanaposhtani M; Asadi M; Sepehri S; Ranjbar PR; Rahimi R; Biglar M; Larijani B; Amanlou M; Mahdavi M
    Arch Pharm (Weinheim); 2020 Sep; 353(9):e2000023. PubMed ID: 32596826
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis, in vitro and in silico studies of novel potent urease inhibitors: N-[4-({5-[(3-Un/substituted-anilino-3-oxopropyl)sulfanyl]-1,3,4-oxadiazol-2-yl}methyl)-1,3-thiazol-2-yl]benzamides.
    Abbasi MA; Hassan M; Aziz-Ur-Rehman ; Siddiqui SZ; Raza H; Shah SAA; Seo SY
    Bioorg Med Chem; 2018 Jul; 26(13):3791-3804. PubMed ID: 29903414
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New thioxothiazolidinyl-acetamides derivatives as potent urease inhibitors: design, synthesis, in vitro inhibition, and molecular dynamic simulation.
    Dastyafteh N; Noori M; Nazari Montazer M; Zomorodian K; Yazdanpanah S; Iraji A; Khalili Ghomi M; Javanshir S; Asadi M; Dianatpour M; Biglar M; Larijani B; Amanlou M; Mahdavi M
    Sci Rep; 2023 Jan; 13(1):21. PubMed ID: 36593349
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design, synthesis, and biological studies of the new cysteine-N-arylacetamide derivatives as a potent urease inhibitor.
    Montazer MN; Asadi M; Moradkhani F; Omrany ZB; Mahdavi M; Amanlou M
    Naunyn Schmiedebergs Arch Pharmacol; 2024 Jan; 397(1):305-315. PubMed ID: 37436497
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis, In Vitro Anti-Microbial Analysis and Molecular Docking Study of Aliphatic Hydrazide-Based Benzene Sulphonamide Derivatives as Potent Inhibitors of α-Glucosidase and Urease.
    Khan S; Iqbal S; Shah M; Rehman W; Hussain R; Rasheed L; Alrbyawi H; Dera AA; Alahmdi MI; Pashameah RA; Alzahrani E; Farouk AE
    Molecules; 2022 Oct; 27(20):. PubMed ID: 36296720
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of synthetic aminoquinoline derivatives as urease inhibitors:
    Seraj F; Khan KM; Iqbal J; Imran A; Hussain Z; Salar U; Hameed S; Taha M
    Future Med Chem; 2023 Sep; 15(18):1703-1717. PubMed ID: 37814798
    [No Abstract]   [Full Text] [Related]  

  • 13. Syntheses, in vitro urease inhibitory activities of urea and thiourea derivatives of tryptamine, their molecular docking and cytotoxic studies.
    Kanwal ; Khan M; Arshia ; Khan KM; Parveen S; Shaikh M; Fatima N; Choudhary MI
    Bioorg Chem; 2019 Mar; 83():595-610. PubMed ID: 30513472
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis of 2-acylated and sulfonated 4-hydroxycoumarins: In vitro urease inhibition and molecular docking studies.
    Rashid U; Rahim F; Taha M; Arshad M; Ullah H; Mahmood T; Ali M
    Bioorg Chem; 2016 Jun; 66():111-6. PubMed ID: 27140727
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hybrid benzothiazole analogs as antiurease agent: Synthesis and molecular docking studies.
    Taha M; Ismail NH; Imran S; Wadood A; Rahim F; Khan KM; Riaz M
    Bioorg Chem; 2016 Jun; 66():80-7. PubMed ID: 27038849
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel 1,3-diaryl pyrazole derivatives bearing methylsulfonyl moiety: Design, synthesis, molecular docking and dynamics, with dual activities as anti-inflammatory and anticancer agents through selectively targeting COX-2.
    Shaker AMM; Shahin MI; AboulMagd AM; Abdel Aleem SA; Abdel-Rahman HM; Abou El Ella DA
    Bioorg Chem; 2022 Dec; 129():106143. PubMed ID: 36191430
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and molecular docking study of piperazine derivatives as potent urease inhibitors.
    Taha M; Wadood A
    Bioorg Chem; 2018 Aug; 78():411-417. PubMed ID: 29689419
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis of new urease enzyme inhibitors as antiulcer drug and computational study.
    Taha M; Ismail S; Imran S; Almandil NB; Alomari M; Rahim F; Uddin N; Hayat S; Zaman K; Ibrahim M; Alghanem B; Islam I; Farooq RK; Boudjelal M; Khan KM
    J Biomol Struct Dyn; 2022 Nov; 40(18):8232-8247. PubMed ID: 33860726
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis of novel N-(1,3-thiazol-2-yl)benzamide clubbed oxadiazole scaffolds: Urease inhibition, Lipinski rule and molecular docking analyses.
    Athar Abbasi M; Raza H; Aziz-Ur-Rehman ; Zahra Siddiqui S; Adnan Ali Shah S; Hassan M; Seo SY
    Bioorg Chem; 2019 Mar; 83():63-75. PubMed ID: 30342387
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis, molecular docking and biological evaluation of some benzimidazole derivatives as potent pancreatic lipase inhibitors.
    Menteşe E; Yılmaz F; Emirik M; Ülker S; Kahveci B
    Bioorg Chem; 2018 Feb; 76():478-486. PubMed ID: 29306066
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.